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Introduction
Definitions and classifications of autoinflammatory
diseases have been multiple. Their succession highlights
the advances in our understanding of the innate immune
system, especially the role of interleukin 1b and the
inflammasome. However, these definitions and classifica-
tions face a number of structure and content issues.
Objectives
To propose a novel definition of autoinflammatory diseases
and to challenge the global classification of inflammatory
diseases.
Methods
We appeal to the desirable characteristics of classification
systems (exhaustiveness, disjointness, naturalness, useful-
ness) and to a critical analysis of the notion of continuum.
Results
We propose a clinically-oriented definition: “autoinflam-
matory diseases are diseases with clinical signs of inflam-
mation, associated with elevated acute phase reactants
and due to a dysfunction in the innate immune system,
genetically determined or triggered by an endogenous
factor”.
It is hard to find natural properties able to underlie a
useful classification of autoinflammatory diseases, and
inflammatory diseases as a whole, into disjoint and exhaus-
tive categories. The notion of continuum is therefore
appealing. However, a single continuum from purely
autoinflammatory to purely autoimmune diseases oversim-
plifies, and even distorts, reality. How to locate, for
instance, the disease caused by a deletion in PLCG2
(the gene encoding phospholipase Cg2) that associates
autoinflammatory symptoms to both common variable
immunodeficiency and autoimmune features? Here
we have an overactivation of both the innate and the
adaptive immune system, associated with a deficiency of
the adaptive immune system.
More than one dimension is needed to properly repre-
sent the immunological dysfunctions underlying inflamma-
tory diseases. Furthermore, a classification of inflammatory
diseases should also make sense of the clinical, pathological
and biological phenotypes.
Conclusion
To be adequate and useful, a definition of autoinflamma-
tory diseases and a classification of inflammatory diseases
must take the multiple facets of reality into account,
including clinical features. This can be done within a con-
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